Suche
Kategorie
Erscheinungsjahr
2057 Treffer
- Haupt, Peter
- Das spätantike Römerkastell von Alzey
- Der Nymphenstein. Bd. 64. Alzey. 2024 S. 4 - 6
- Fillmann, Elisabeth
- Bärenstark: Zum Lied "Gud, du er min tilflukt -Gott, du bist meine Zuflucht-" der norwegischen Autorin Ingrid Brækken Melve
- Lüstraeten, Martin; Schäfer, Christiane; Zerfaß, Alexander (Hrsg). Erkundungen zum Kirchenlied: Festschrift für Ansgar Franz. Tübingen: Narr Francke Attempto 2024 S. 159 - 172 (Pietas Liturgica 17)
- Haupt, Peter
- Nützlicher Unfug? Kraftorte im Bliesgau
- Saarpfalz: Zeitschrift für Geschichte und Regionalkultur. Bd. 151. H. 1. Homburg / Saar. 2024 S. 52 - 57
- Lehnardt, Andreas
- "Moses and Aaron went to Egypt" - Tibåt Mårqe and Rabbinic Literature
- Zsengellér, Jozséf (Hrsg). Samaritans through the Ages: Studies on Samaritan History, Texts, Interpretation, Linguistics and Manuscripts. Berlin: deGruyter 2024 S. 59 - 89 (Studia Samaritana 14)
- Holch, Julian Walter; Ohnmacht, Alexander; Stintzing, Sebastian et al.
- Refining first-line treatment decision in RAS wildtype (RAS-WT) metastatic colorectal cancer (mCRC) by combining clinical biomarkers: Results of the randomized phase 3 trial FIRE-3 (AIO KRK0306).
- JOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 3_SUPPL. 2024 S. 13-13
- Cruz-Correa, Marcia; Xu, Rui-Hua; Moehler, Markus H. et al.
- Tislelizumab (TIS) plus chemotherapy (Chemo) vs placebo (PBO) plus chemo as first-line (1L) treatment of advanced gastric or gastroesophageal junction adenocarcinoma (GC/GEJC): Health-related quality of life (HRQoL) outcomes in the RATIONALE-305 study.
- JOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 3_SUPPL. 2024 S. 290-290
- Weiss, Lena; Stintzing, Sebastian; Modest, Dominik Paul et al.
- Efficacy of FOLFIRI plus bevacizumab versus FOLFIRI plus cetuximab in RAS-mutant metastatic colorectal cancer: Final update on patients with RAS-mutant metastatic colorectal cancer treated in FIRE-3
- JOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 16. 2024
- Kroese, Tiuri E.; Bronzwaer, Sebastiaan; van Rossum, Peter S. N. et al.
- European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4)
- EUROPEAN JOURNAL OF CANCER. Bd. 204. 2024
- Elimova, Elena; Shitara, Kohei; Moehler, Markus H. et al.
- Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 4-year follow-up of CheckMate 649
- JOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 16. 2024
- Siebenhuener, Alexander Rheinhard; Ruhstaller, Thomas; Planas-Paz, Lara et al.
- Whole transcriptome analysis to reveal epithelial-mesenchymal transition after neoadjuvant therapy with or without additional anti-EGFR treatment: Subgroup analysis of esophageal squamous cell carcinomas of the SAKK 75/08 and the EORTC AIO POWER study
- JOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 16. 2024